Stay updated on Darolutamide in Hormone Sensitive Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Darolutamide in Hormone Sensitive Prostate Cancer Clinical Trial page.

Latest updates to the Darolutamide in Hormone Sensitive Prostate Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe record history now displays a new revision entry labeled v3.6.6. The previous revision v3.6.5 was removed.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedNew version entry added to the Study Record History: Revision: v3.6.5. This indicates a recent update to the record since the previous version (v3.6.4).SummaryDifference0.1%

- Check47 days agoChange DetectedThe page history now shows a new revision label, updating from Revision: v3.6.3 to Revision: v3.6.4. This indicates a minor update to the page's record.SummaryDifference0.1%

- Check62 days agoChange DetectedTwo new sections, Contacts/Locations and Study Status, were added to the study history page on 2026-07-07, improving access to contact details and the current study status. A prior entry from 2026-06-22 was removed from the history.SummaryDifference0.3%

- Check69 days agoChange DetectedA new revision entry (v3.6.3) was added to the history, replacing the previous v3.6.2. This indicates an incremental update to the study record's documentation.SummaryDifference0.1%

- Check76 days agoChange DetectedA new version entry (38) is added to the record history, including updates to Study Status and Contacts/Locations and recorded as Revision: v3.6.2. The previous revision (v3.6.0) was removed.SummaryDifference0.4%

Stay in the know with updates to Darolutamide in Hormone Sensitive Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Darolutamide in Hormone Sensitive Prostate Cancer Clinical Trial page.